Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

RICTOR amplification identifies a subgroup in small cell lung cancer and predicts response to drugs targeting mTOR

15 Nov 2016

Abstract excerpt

// Nneha Sakre 1, 2 , Gary Wildey 1, 2 , Mohadese Behtaj 3 , Adam Kresak 1, 3 , Michael Yang 3 , Pingfu Fu 4 , Afshin Dowlati 1, 2 1 Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio, 44106 USA 2 Division of Hematology and Oncology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106 USA 3 Department of Pathology, University Hospitals Cleveland Medical Center,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Lung Cancer Research Studies
Share to Neuroendocrine Tumor Research Advances

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27863413
DOI: 10.18632/oncotarget.13362

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

RICTOR amplification identifies a subgroup in small cell lung cancer and predicts response to drugs targeting mTORPMID 27863413Read ↗

RICTOR Amplification Defines a Novel Subset of Patients with Lung Cancer Who May Benefit from Treatment with mTORC1/2 Inhibitors.Semantic proximity Read ↗

Molecular co-alteration patterns of RICTOR-mutant metastatic lung adenocarcinomas: a single-center cohort study.Semantic proximity Read ↗

Prognostic significance of RICTOR mutations in EGFR-mutant metastatic lung adenocarcinoma: a retrospective cohort study.Semantic proximity Read ↗

Clinical correlation of extensive-stage small-cell lung cancer genomics.Semantic proximity Read ↗

Next-generation sequencing reveals frequent consistent genomic alterations in small cell undifferentiated lung cancer.Semantic proximity Read ↗

Reciprocal expression of INSM1 and YAP1 defines subgroups in small cell lung cancerSemantic proximity Read ↗

Therapeutic priority of the PI3K/AKT/mTOR pathway in small cell lung cancers as revealed by a comprehensive genomic analysis.Semantic proximity Read ↗

Multi-region exome sequencing reveals the intratumoral heterogeneity of surgically resected small cell lung cancer.Semantic proximity Read ↗

Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumorsSemantic proximity Read ↗

A Comprehensive Pan-Cancer Analysis of the Potential Biological Functions and Prognosis Values of RICTORSemantic proximity Read ↗

[Comprehensive Genomic Analysis for Small Cell Lung Cancer].Semantic proximity Read ↗

Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.